Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Identifieur interne : 000106 ( PubMed/Checkpoint ); précédent : 000105; suivant : 000107Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Auteurs : Michelle C. Crank [États-Unis] ; John R. Mascola [États-Unis] ; Barney S. Graham [États-Unis]Source :
- The Journal of infectious diseases [ 1537-6613 ] ; 2019.
Descripteurs français
- KwdFr :
- Animaux, Anticorps antiviraux (immunologie), Antigènes viraux (génétique), Antigènes viraux (immunologie), Dérive génétique, Grippe humaine (), Grippe humaine (transmission), Grippe humaine (virologie), Grippe humaine (épidémiologie), Humains, Infections à Orthomyxoviridae (immunologie), Infections à Orthomyxoviridae (virologie), Lymphocytes B (immunologie), Lymphocytes T CD4+ (immunologie), Lymphocytes T CD8+ (immunologie), Modèles animaux de maladie humaine, Pandémies (), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (normes), Vaccins atténués (immunologie), Virus de la grippe A (génétique), Virus de la grippe A (immunologie), Virus de la grippe A (isolement et purification), Épitopes immunodominants (immunologie).
- MESH :
- génétique : Antigènes viraux, Virus de la grippe A.
- immunologie : Anticorps antiviraux, Antigènes viraux, Infections à Orthomyxoviridae, Lymphocytes B, Lymphocytes T CD4+, Lymphocytes T CD8+, Vaccins antigrippaux, Vaccins atténués, Virus de la grippe A, Épitopes immunodominants.
- isolement et purification : Virus de la grippe A.
- normes : Vaccins antigrippaux.
- virologie : Grippe humaine, Infections à Orthomyxoviridae.
- épidémiologie : Grippe humaine.
- Animaux, Dérive génétique, Grippe humaine, Humains, Modèles animaux de maladie humaine, Pandémies.
English descriptors
- KwdEn :
- Animals, Antibodies, Viral (immunology), Antigens, Viral (genetics), Antigens, Viral (immunology), B-Lymphocytes (immunology), CD4-Positive T-Lymphocytes (immunology), CD8-Positive T-Lymphocytes (immunology), Disease Models, Animal, Gain of Function Mutation, Genetic Drift, Humans, Immunodominant Epitopes (immunology), Influenza A virus (genetics), Influenza A virus (immunology), Influenza A virus (isolation & purification), Influenza Vaccines (immunology), Influenza Vaccines (standards), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Influenza, Human (transmission), Influenza, Human (virology), Orthomyxoviridae Infections (immunology), Orthomyxoviridae Infections (virology), Pandemics (prevention & control), Vaccines, Attenuated (immunology).
- MESH :
- chemical , genetics : Antigens, Viral.
- chemical , immunology : Antibodies, Viral, Antigens, Viral, Immunodominant Epitopes, Influenza Vaccines, Vaccines, Attenuated.
- epidemiology : Influenza, Human.
- genetics : Influenza A virus.
- immunology : B-Lymphocytes, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Influenza A virus, Orthomyxoviridae Infections.
- isolation & purification : Influenza A virus.
- prevention & control : Influenza, Human, Pandemics.
- chemical , standards : Influenza Vaccines.
- transmission : Influenza, Human.
- virology : Influenza, Human, Orthomyxoviridae Infections.
- Animals, Disease Models, Animal, Gain of Function Mutation, Genetic Drift, Humans.
DOI: 10.1093/infdis/jiz043
PubMed: 30715413
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:30715413Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</title>
<author><name sortKey="Crank, Michelle C" sort="Crank, Michelle C" uniqKey="Crank M" first="Michelle C" last="Crank">Michelle C. Crank</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Graham, Barney S" sort="Graham, Barney S" uniqKey="Graham B" first="Barney S" last="Graham">Barney S. Graham</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:30715413</idno>
<idno type="pmid">30715413</idno>
<idno type="doi">10.1093/infdis/jiz043</idno>
<idno type="wicri:Area/PubMed/Corpus">000172</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000172</idno>
<idno type="wicri:Area/PubMed/Curation">000172</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000172</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000106</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000106</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</title>
<author><name sortKey="Crank, Michelle C" sort="Crank, Michelle C" uniqKey="Crank M" first="Michelle C" last="Crank">Michelle C. Crank</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Graham, Barney S" sort="Graham, Barney S" uniqKey="Graham B" first="Barney S" last="Graham">Barney S. Graham</name>
<affiliation wicri:level="2"><nlm:affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
<wicri:cityArea>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">The Journal of infectious diseases</title>
<idno type="eISSN">1537-6613</idno>
<imprint><date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antibodies, Viral (immunology)</term>
<term>Antigens, Viral (genetics)</term>
<term>Antigens, Viral (immunology)</term>
<term>B-Lymphocytes (immunology)</term>
<term>CD4-Positive T-Lymphocytes (immunology)</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Disease Models, Animal</term>
<term>Gain of Function Mutation</term>
<term>Genetic Drift</term>
<term>Humans</term>
<term>Immunodominant Epitopes (immunology)</term>
<term>Influenza A virus (genetics)</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza A virus (isolation & purification)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza Vaccines (standards)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Influenza, Human (transmission)</term>
<term>Influenza, Human (virology)</term>
<term>Orthomyxoviridae Infections (immunology)</term>
<term>Orthomyxoviridae Infections (virology)</term>
<term>Pandemics (prevention & control)</term>
<term>Vaccines, Attenuated (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Anticorps antiviraux (immunologie)</term>
<term>Antigènes viraux (génétique)</term>
<term>Antigènes viraux (immunologie)</term>
<term>Dérive génétique</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (transmission)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Infections à Orthomyxoviridae (immunologie)</term>
<term>Infections à Orthomyxoviridae (virologie)</term>
<term>Lymphocytes B (immunologie)</term>
<term>Lymphocytes T CD4+ (immunologie)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Pandémies ()</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins antigrippaux (normes)</term>
<term>Vaccins atténués (immunologie)</term>
<term>Virus de la grippe A (génétique)</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Virus de la grippe A (isolement et purification)</term>
<term>Épitopes immunodominants (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Antigens, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
<term>Antigens, Viral</term>
<term>Immunodominant Epitopes</term>
<term>Influenza Vaccines</term>
<term>Vaccines, Attenuated</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Antigènes viraux</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Antigènes viraux</term>
<term>Infections à Orthomyxoviridae</term>
<term>Lymphocytes B</term>
<term>Lymphocytes T CD4+</term>
<term>Lymphocytes T CD8+</term>
<term>Vaccins antigrippaux</term>
<term>Vaccins atténués</term>
<term>Virus de la grippe A</term>
<term>Épitopes immunodominants</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>B-Lymphocytes</term>
<term>CD4-Positive T-Lymphocytes</term>
<term>CD8-Positive T-Lymphocytes</term>
<term>Influenza A virus</term>
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="standards" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Infections à Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
<term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Gain of Function Mutation</term>
<term>Genetic Drift</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Dérive génétique</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Pandémies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30715413</PMID>
<DateCompleted><Year>2020</Year>
<Month>05</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>05</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>219</Volume>
<Issue>Suppl_1</Issue>
<PubDate><Year>2019</Year>
<Month>04</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of infectious diseases</Title>
<ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.</ArticleTitle>
<Pagination><MedlinePgn>S107-S109</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiz043</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crank</LastName>
<ForeName>Michelle C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mascola</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Graham</LastName>
<ForeName>Barney S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo><Affiliation>Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Infect Dis</MedlineTA>
<NlmUniqueID>0413675</NlmUniqueID>
<ISSNLinking>0022-1899</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016056">Immunodominant Epitopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073659" MajorTopicYN="N">Gain of Function Mutation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D040961" MajorTopicYN="N">Genetic Drift</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016056" MajorTopicYN="N">Immunodominant Epitopes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Influenza</Keyword>
<Keyword MajorTopicYN="Y">Pandemic</Keyword>
<Keyword MajorTopicYN="Y">Vaccine</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>5</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2019</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">30715413</ArticleId>
<ArticleId IdType="pii">5304928</ArticleId>
<ArticleId IdType="doi">10.1093/infdis/jiz043</ArticleId>
<ArticleId IdType="pmc">PMC6452294</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacol Ther. 2009 Sep;86(3):234-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19707212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 2013 Sep;255(1):230-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23947359</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2018 Jan;19(1):20-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29199281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 2018 Feb 1;96(2):129-134</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29403116</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2018 Jul 2;218(3):347-354</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29506129</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2018 Apr 10;319(14):1431-1432</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29566112</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S38-S45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30535315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S97-S106</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715348</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S5-S13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715352</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S62-S67</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S75-S80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715357</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S88-S96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715361</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S68-S74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S14-S20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715371</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S21-S29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715373</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S30-S37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S57-S61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S81-S87</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715386</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S46-S56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715467</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2019 Apr 8;219(Supplement_1):S1-S4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30715469</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Crank, Michelle C" sort="Crank, Michelle C" uniqKey="Crank M" first="Michelle C" last="Crank">Michelle C. Crank</name>
</region>
<name sortKey="Graham, Barney S" sort="Graham, Barney S" uniqKey="Graham B" first="Barney S" last="Graham">Barney S. Graham</name>
<name sortKey="Mascola, John R" sort="Mascola, John R" uniqKey="Mascola J" first="John R" last="Mascola">John R. Mascola</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000106 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000106 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:30715413 |texte= Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:30715413" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
This area was generated with Dilib version V0.6.34. |